Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in France
Date:7/7/2009

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has established a distribution partnership in France through Medipartner, a Paris based firm specializing in the marketing and distribution of innovative gastrointestinal medical devices. The Company believes that building an effective distribution network in France will also enhance sales in the emerging North African and Middle Eastern markets due to their relationship with France.

Michel Vaudry, SpectraScience's VP of Sales and Marketing, said, "We are pleased to add Medipartner to our expanding distribution footprint throughout Europe, and are optimistic that physicians and more importantly, patients in France will greatly benefit from the introduction of WavSTAT to this market. In terms of cancers plaguing France's population, colon cancer has one of the highest rates of incidence and mortality."

Medipartner's Chief Executive, Christian Arnould, stated that, "We decided to add the WavSTAT to products that we distribute because it is both innovative and it will translate into progress for cancer detection. Our focus is in the gastrointestinal market, and based on our experience and understanding of that market, I think that the WavSTAT is a great fit for us, and our customers." Medipartner is the French distributor for Sandhill Scientific, a leading international GI diagnostics company based in Colorado.

"We are shipping a unit to France this week," added Vaudry. "I will be going to France to assist Christian in making demonstrations of the WavSTAT to physicians at several healthcare centers of excellence, including the Hospital Edourard Herriot in Lyon, which has just been ranked as one of the 10 best healthcare centers in the world by Newsweek magazine." In addition, Mr. Vaudry noted that Lyon is the headquarters of the International Agency for Research on Cancer (IARC), one of the most prestigious cancer research facilities in operation today.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. In addition, the Company's LUMA(R) Cervical Imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available today.

    Contact:

    SpectraScience, Inc.                         Hayden
    Communications                               Investor Relations

    Jim Hitchin, Chief Executive Officer         Todd Pitcher
    (858) 847-0200 x 201                         (858)-518-1387

   http://www.spectrascience.com


'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Spain
2. SpectraScience Receives FDA Clearance for Manufacturing Facility
3. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
4. SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement
5. SpectraScience Announces Business Update
6. SpectraScience Awarded U.S. Patent 7,469,160 for Its Unique Methods and Apparatus for Evaluating Image Focus
7. SpectraScience Awarded U.S. Patent 7,459,696 for its Unique Methods of Calibrating Spectral Data
8. SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis
9. SpectraScience Announces Updates
10. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
11. SpectraScience Awarded Patent for Correcting Image Misalignment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines ... despite scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases ... Kenneth B. Liegner, M.D. has compiled into a single volume a compelling argument that ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... clinic serving San Francisco and environs, is proud to announce an upgrade to ... information on the upgraded Yelp page on topics as diverse as Platelet Rich ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/25/2017)... ... , ... FCPX users now have the ability to sharpen a desired color ... users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, ... users can visually see the color range effected with ease all within Final ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017 Report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Latin America , ... for the period 2015 through 2022. Also, a six-year historic ... are derived from primary and secondary research. Company profiles are ...
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... -- This report analyzes the worldwide markets for Chiral Technology ... Products: Intermediates, Analytical, and Others. The End Use markets ... The report provides separate comprehensive analytics for the US, ... , and Rest of World. Annual estimates and forecasts ... a six-year historic analysis is provided for these markets. ...
Breaking Medicine Technology: